In summary, our data identify PERK-eIF2a-ATF4-CHOP pathway as a new mechanism of apoptosis induced by 125I and suggest that PERK-eIF2a-ATF4-CHOP pathway could be a new therapeutic target in 125I seed implantation therapy for HCC. Here, ATF4 is linked to hepatocellular carcinoma.